139 related articles for article (PubMed ID: 16473648)
21. A review of the pulmonary toxicity of cancer chemotherapeutic agents.
Weiss RB; Trush DM
Oncol Nurs Forum; 1982; 9(1):16-21. PubMed ID: 6916364
[No Abstract] [Full Text] [Related]
22. Mechanisms of drug-induced lung disease.
Martin WJ
J Lab Clin Med; 1993 Feb; 121(2):195-6. PubMed ID: 8433033
[No Abstract] [Full Text] [Related]
23. [Pulmonary complications in chemotherapy].
Becker A; Frauenfelder T
Radiologe; 2014 Oct; 54(10):1023-38. PubMed ID: 25316105
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary toxicity in cancer chemotherapy.
Green MR
Ann Intern Med; 1979 Sep; 91(3):502. PubMed ID: 475202
[No Abstract] [Full Text] [Related]
25. Fatal pulmonary toxicity after a single dose of cyclophosphamide.
Gupta S; Mahipal A
Pharmacotherapy; 2007 Apr; 27(4):616-8. PubMed ID: 17381391
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary veno-occlusive disease after chemotherapy.
Ellis DA; Capewell SJ
Thorax; 1986 May; 41(5):415-6. PubMed ID: 3750252
[No Abstract] [Full Text] [Related]
27. [Drug-induced pneumopathy].
Chugalin AG
Ter Arkh; 1991; 63(3):4-11. PubMed ID: 1676545
[No Abstract] [Full Text] [Related]
28. Pulmonary toxicity and cancer treatment.
Fennell DA; Rudd RM
Hosp Med; 2004 Aug; 65(8):462-5. PubMed ID: 15330346
[TBL] [Abstract][Full Text] [Related]
29. [Pulmonary toxicity due to interleukin-2].
de la Torre Ramos MA; Moneo González A; Tolón Herrera MJ; Fernández Muñoz R
Med Intensiva; 2007 Oct; 31(7):412-3. PubMed ID: 17942067
[No Abstract] [Full Text] [Related]
30. [Lung injury].
Saito Y; Gemma A
Nihon Rinsho; 2012 Aug; 70 Suppl 6():159-65. PubMed ID: 23156502
[No Abstract] [Full Text] [Related]
31. [Medicines to be cautiously used on pneumoconiosis patients].
Xu AX; Zhu JM; Jia B
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb; 22(1):74. PubMed ID: 15033034
[No Abstract] [Full Text] [Related]
32. Lymphomatoid granulomatosis induced by imatinib-treatment.
Yazdi AS; Metzler G; Weyrauch S; Berneburg M; Bitzer M; Müller-Hermelink HK; Röcken M
Arch Dermatol; 2007 Sep; 143(9):1222-3. PubMed ID: 17875901
[No Abstract] [Full Text] [Related]
33. Gastrointestinal toxicity of chemotherapeutic agents.
Mitchell EP
Semin Oncol; 2006 Feb; 33(1):106-20. PubMed ID: 16473649
[TBL] [Abstract][Full Text] [Related]
34. [Drugs and iatrogenically induced pulmonary toxicity].
Mihălţan F
Pneumoftiziologia; 1991; 40(1):15-23. PubMed ID: 1823192
[No Abstract] [Full Text] [Related]
35. [Myelotoxicity due to chemotherapy in oncology practice].
Geoffrois L
Rev Prat; 2006 Nov; 56(18):2009-14. PubMed ID: 17274503
[TBL] [Abstract][Full Text] [Related]
36. Central and peripheral nervous system toxicity of common chemotherapeutic agents.
Sioka C; Kyritsis AP
Cancer Chemother Pharmacol; 2009 Apr; 63(5):761-7. PubMed ID: 19034447
[TBL] [Abstract][Full Text] [Related]
37. Late toxicity in survivors from adolescent cancers.
Pentheroudakis G; Pavlidis N
Cancer Treat Rev; 2007 Nov; 33(7):656-63. PubMed ID: 17640814
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy and the gastrointestinal tract.
Holmes S
Nurs Times; 1984 Feb 22-28; 80(8):28-31. PubMed ID: 6561578
[No Abstract] [Full Text] [Related]
39. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues.
Chen Y; Jungsuwadee P; Vore M; Butterfield DA; St Clair DK
Mol Interv; 2007 Jun; 7(3):147-56. PubMed ID: 17609521
[TBL] [Abstract][Full Text] [Related]
40. Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.
Narimatsu H; Hori A; Matsumura T; Kodama Y; Takita M; Kishi Y; Hamaki T; Yuji K; Tanaka Y; Komatsu T; Kami M
J Clin Oncol; 2008 Dec; 26(35):5820-3. PubMed ID: 19001340
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
